Integrative discovery of CD98 as a melanoma biomarker

Pigment Cell Melanoma Res. 2016 May;29(3):385-7. doi: 10.1111/pcmr.12464. Epub 2016 Apr 10.

Authors

Nicholas Theodosakis¹, Goran Micevic¹, Reema Sharma², Alexander S Baras², Rossitza Lazova^{1

3}, Marcus W Bosenberg^{1

3}, Nemanja Rodić³

Affiliations

¹ Department of Pathology, Yale University, New Haven, CT, USA.
² Department of Pathology, The Johns Hopkins University, Baltimore, MD, USA.
³ Department of Dermatology, Division of Dermatopathology, Yale University, New Haven, CT, USA.

PMID: 26850337
DOI: 10.1111/pcmr.12464

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / metabolism*
Disease Progression
Fusion Regulatory Protein-1 / metabolism*
Humans
Melanoma / metabolism*
Melanoma / pathology
Neoplasm Invasiveness
Proteomics*

Substances

Biomarkers, Tumor
Fusion Regulatory Protein-1

Grants and funding

F30 CA196089/CA/NCI NIH HHS/United States